 | Up a level |
Sotoodeh jahromi, Abdolreza and Ahmadi-Vasmehjani, Abbas and Zabetian, Hassan and Hakimelahi, Hossein and Yusefi, Alireza and Sanie, Mohammad Sadegh and Talebnia Jahromi, S and Ghanei, M and Sapidkar, A and Erfanian, Saeideh and Madani, A and Kafilzadeh, Farshid and Kargar, M and Hojjat-Farsangi, M (2016) Sero-Epidemiological Study of Hepatitis E Virus among Thalassemia as High Risk Patients: A Cross-Sectional Survey in Jahrom, Southern, Iran. Glob J Health Sci, 8 (9).
Khamisipour, G and Jadidi-Niaragh, F and Jahromi, AS and Zandi, K and Hojjat-Farsangi, M (2016) Mechanisms of tumor cell resistance to the current targeted-therapy agents. Tumour Biol, 37 (8). pp. 10021-10039.
Kokhaei, P and Jadidi-Niaragh, F and Sotoodeh Jahromi, A and Osterborg, A and Mellstedt, H and Hojjat-Farsangi, M (2016) Ibrutinib-A double-edge sword in cancer and autoimmune disorders. Journal of drug targeting, 24 (5).
Maalhagh, M and Shojaei, M and Erfanian, S and Sotoodeh Jahromi, A and Sanei, M.S and Yousefi, A and Zabetian, H and Hakimelahi, H and Madani, A and Hojjat-Farsangi, M (2015) Lack of Association Between rs17568 Polymorphism in OX40 Gene and Myocardial Infarction, Southern of Iran. Glob J Health Sci, 8 (6). pp. 41-46.
